National Ophthalmology Database Audit: Year 3 Annual Report – The Second Prospective Report of the National Ophthalmology Database Audit – Healthcare Quality Improvement Partnership

National Ophthalmology Database (NOD) cataract audit to report on all NHS funded cataract surgery in England and Wales. Included in this second prospective report are operations undertaken between 1st September 2016 and 31st August 2017. For comparisons with results from the first year of

National Bowel Cancer Audit: The feasibility of reporting Patient Reported Outcome Measures as part of a national colorectal cancer audit – Healthcare Quality Improvement Partnership

A feasibility study linking the NHS England National Cancer PROM’s to the National Bowel Cancer Audit (NBOCA) data to establish the feasibility of the PROMs as part of the national clinical audit. This was assessed according to: the characteristics of

Assessment of delirium in hospital for people with dementia: Spotlight audit 2017–2018 – Healthcare Quality Improvement Partnership

The National Audit of Dementia (care in general hospitals) (NAD) examines aspects of care received by people with dementia in general hospitals in England and Wales. In addition, NAD provides national and local reports to support hospitals to identify areas

Familial Hypercholesterolaemia: Implementing a systems approach to detection and management – Public Health England

This guide provides further information on the recently updated NICE Guideline (CG71) Familial Hypercholesterolaemia: identification and management. It includes: a summary of recommendations from the recent update of the document an outline of national and European policy documents best practice case

Mechanical thrombectomy devices for acute ischaemic stroke: Medtech innovation briefing [MIB153] – NICE

Thetechnologies described in this briefing are 21 mechanical thrombectomy devices of 2 types: stent retrievers and aspiration catheters. They are used to remove blood clots from a main cerebral artery to restore blood flow after acute ischaemic stroke. The innovative aspects are that

Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healing: Interventional procedures guidance [IPG622] – NICE

Evidence-based recommendations on low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healing in adults. This involves using an ultrasound probe on the skin at the site of the fracture. The evidence for low-intensity pulsed ultrasound

Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures [IPG623] – NICE

Evidence-based recommendations on low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures in adults. This involves using an ultrasound probe on the skin at the site of the fracture. The evidence for low-intensity pulsed ultrasound to promote healing

Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing: Interventional procedures guidance [IPG621] – NICE

Evidence-based recommendations on low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing in adults. This involves using an ultrasound probe on the skin at the site of the fracture. The evidence for low-intensity pulsed ultrasound

Dupilumab for treating moderate to severe atopic dermatitis: Technology appraisal guidance [TA534] – NICE

Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults. Dupilumab is recommended as an option for treating moderate to severe atopic dermatitis in adults, only if: the disease has not responded to at least 1 other

Endometriosis: Quality standard [QS172] – NICE

This quality standard covers diagnosing and managing endometriosis in women, including young women aged 17 and under. It describes high-quality care in priority areas for improvement.

Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs: Technology appraisal guidance [TA537] – NICE

Evidence-based recommendations on ixekizumab (Taltz) for treating active psoriatic arthritis in adults. Ixekizumab alone, or with methotrexate, is recommended as an option for treating active psoriatic arthritis in adults, only if: it is used as described in NICE’s technology appraisal

Intermediate care including reablement: Quality standard [QS173] – NICE

This quality standard covers referral and assessment for intermediate care and how to deliver the service. It covers bed-based intermediate care, crisis response, home-based intermediate care and reablement. It describes high-quality care in priority areas for improvement. It does not

Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine: Technology appraisal guidance [TA535] – NICE

Evidence-based recommendations on lenvatinib (Lenvima) and sorafenib (Nexavar) for progressive, locally advanced or metastatic differentiated thyroid cancer in adults who have had radioactive iodine. Lenvatinib and sorafenib are recommended as options for treating progressive, locally advanced or metastatic differentiated thyroid

Meeting urgent needs: improving out of hours services in Wales – Royal College of General Practitioners

Report from the Royal College of General Practitioners Wales that calls for better use of a wider primary care team, better use of technology, clearer national guidance for those working in the services, and measures to address the wider issues

Always Events: Evaluation Phase 4: Scale-up and spread – Picker

Always Events are aspects of the patient experience that are so important to patients and family members that health care providers must aim to perform them consistently for every individual, every time. The aim of this report is to detail the

Screening Quality Assurance Visit Report: NHS Bowel Cancer Screening Programme West London Bowel Cancer Screening Centre – Public Health England

The findings in this report relate to the quality assurance (QA) visit of West London Bowel Cancer Screening Programme held on 2 November 2017. Finds the West London bowel cancer screening programme is well supported by the director of screening

Screening Quality Assurance visit report: NHS Bowel Cancer Screening Programme Norfolk and Norwich – Public Health England

The findings in this report relate to the quality assurance visit of the Norfolk and Norwich screening service held on 15 November 2017. Finds this well-led and resilient bowel screening team is at the forefront of bowel screening in England. The enthusiastic

Screening Quality Assurance visit report: NHS Abdominal Aortic Aneurysm Screening Programme North West London – Public Health England

The findings in this report relate to the quality assurance (QA) visit of the North West London abdominal aortic aneurysm (AAA) screening service held on 26 September 2017. The programme meets 12 out of the 16 measurable pathway standards for the NHS

NHS England Emergency Preparedness, Resilience and Response annual assurance guidance – NHS England

This guidance document has been produced to provide guidance to organisations completing the Emergency Preparedness, Resilience and Response (EPRR) annual assurance process.  

Evaluation Of The Implementation Of The Saving Babies’ Lives Care Bundle In Early Adopter NHS Trusts In England – University of Manchester

University of Manchester evaluation of the Saving Babies Lives Care Bundle that demonstartes clinical improvements such as better monitoring of a baby’s growth and movement in pregnancy, as well as better monitoring in labour, led to maternity staff helping to